Valuation Cipher Pharmaceuticals Inc.

Stocks

Market Closed - Toronto S.E. 23:00:00 16/10/2026 +03			5-day change	1st Jan Change
13.25 ^CAD	-2.07%		-2.93%	-12.02%

09-22	Cipher Pharmaceuticals Inc. Announces Appointment of Rajiv De Silva to Board of Directors, Effective September 21, 2026	CI
09-02	Cipher Pharmaceuticals' Ownership Of Certain Abscoria-Related Clinical Data Affirmed by US Court	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	46.45	96.48	133.1	366.4	382.2	343.9	-	-
Change	-	107.72%	37.94%	175.35%	4.29%	-10.02%	-	-
Enterprise Value (EV)	46.45	96.48	133.1	366.4	382.2	343.9	343.9	343.9
Change	-	107.72%	37.94%	175.35%	4.29%	-10.02%	0%	0%
P/E	4.83x	2.71x	5.12x	21.8x	10.5x	12x	11.1x	10.8x
PBR	0.93x	1.11x	1.29x	2.47x	2.23x	1.68x	1.44x	1.26x
PEG	-	0x	-0.2x	-0.6x	0x	-0.6x	1.38x	3.06x
Capitalization / Revenue	1.67x	3.39x	4.65x	7.68x	5.56x	4.85x	4.23x	4.02x
EV / Revenue	0x	0x	0x	0x	0x	4.85x	4.23x	4.02x
EV / EBITDA	0x	0x	0x	0x	0x	8.34x	7.09x	6.56x
EV / EBIT	-	-	-	-	-	-	-	-
EV / FCF	-	-	-	-	0x	9.43x	-	-
FCF Yield	-	-	-	-	10.6%	10.6%	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	0.3666	1.417	1.081	0.658	1.43	1.124	1.214	1.256
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	27.74	28.43	28.6	47.72	68.73	70.85	81.35	85.63
EBITDA ¹	17.59	17.11	17.19	22.43	38.22	41.25	48.49	52.44
EBIT	-	-	-	-	-	-	-	-
Net income ¹	9.807	36.63	27.55	16.51	37.23	27.7	31.76	32.77
Net Debt	-	-	-	-	-	-	-	-
Reference price ²	1.77	3.84	5.54	14.32	15.06	13.53	13.53	13.53
Nbr of stocks (in thousands)	26,241	25,124	24,022	25,590	25,377	25,415	-	-
Announcement Date	3/17/22 A	3/16/23 A	3/14/24 A	3/18/25 A	3/12/26 A	-	-	-

¹CAD in Million²CAD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
CIPHER PHARMACEUTICALS INC.	12.04x	-	-	-	242M
ELI LILLY AND COMPANY	35.8x	12.9x	27.02x	0.55%	1,116B
JOHNSON & JOHNSON	37.07x	6.25x	17.38x	2.11%	610B
ABBVIE INC.	36.17x	8.31x	17.13x	2.45%	501B
MERCK & CO., INC.	112.15x	5.92x	25.35x	2.35%	358B
ROCHE HOLDING AG	20.49x	5x	12.4x	2.64%	366B
NOVARTIS AG	21.24x	5.55x	13.66x	2.88%	288B
ASTRAZENECA PLC	22x	4.43x	12.71x	1.99%	261B
AMGEN INC.	27.56x	7.08x	12.68x	2.32%	235B
GILEAD SCIENCES, INC.	-45.98x	7.04x	27.26x	2.1%	195B
Average	27.85x	6.94x	18.40x	2.15%	393B
Weighted average by Cap.	35.04x	8.17x	19.98x	1.84%